Vascular complications of scleroderma
Tài liệu tham khảo
Kahaleh, 2004, Vascular involvement in systemic sclerosis, Clin Exp Rheumatol, 22, S19
Matuc-Cicerinic, 1997, New approaches to Raynaud's phenomenon, Curr Opin Rheumatol, 544, 9
Cutolo, 2003, Raynaud's phenomenon and the role of capillaroscopy, Arthritis Rheum, 48, 3023, 10.1002/art.11310
Maricq, 1981, Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders, Arthritis Rheum, 24, 1159, 10.1002/art.1780240907
Kabasakal, 1996, Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls, Ann Rheum Dis, 55, 507, 10.1136/ard.55.8.507
Maricq, 1980, Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders, Arthritis Rheum, 23, 183, 10.1002/art.1780230208
Andrade, 1990, Panoramic nailfold capillaroscopy: a new reading method and normal range, Semin Arthritis Rheum, 20, 21, 10.1016/0049-0172(90)90091-S
LeRoy, 1996, Systemic sclerosis. A vascular perspective, Rheum Dis Clin North Am, 22, 675, 10.1016/S0889-857X(05)70295-7
Maricq, 1983, Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease, Clin Exp Rheumatol, 1, 195
Steen, 1990, Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin-converting enzyme (ACE) inhibitors, Ann Intern Med, 113, 352, 10.7326/0003-4819-113-5-352
Coghlan, 2001, The heart and pulmonary vasculature in scleroderma: clinical features and pathobiology, Curr Opin Rheumatol, 13, 495, 10.1097/00002281-200111000-00008
Steen, 2005, Advancements in diagnosis of pulmonary arterial hypertension in scleroderma, Arthritis Rheum, 52, 3698, 10.1002/art.21613
Ramirez, 2004, Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management, Treat Respir Med, 3, 339, 10.2165/00151829-200403060-00002
Hebbar, 2000, Increased concentration of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis, Arthritis Rheum, 43, 889, 10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5
Hachulla, 2005, Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study, Arthritis Rheum, 52, 3792, 10.1002/art.21433
Robertson, 2005, Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach, Ann Rheum Dis, 64, 804, 10.1136/ard.2004.026427
Galie, 2004, Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension, J Am Coll Cardiol, 43, 81, 10.1016/j.jacc.2004.02.038
Badesch, 2000, Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial, Ann Intern Med, 132, 425, 10.7326/0003-4819-132-6-200003210-00002
Channick, 2001, New and experimental therapies for pulmonary hypertension, Clin Chest Med, 22, 539, 10.1016/S0272-5231(05)70290-2
White, 2000, Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis, Ann Intern Med, 132, 947, 10.7326/0003-4819-132-12-200006200-00004
Giacomelli, 2002, Cyclophosphamide pulse regimen for the treatment of alveolitis in systemic sclerosis, J Rheumatol, 29, 731
Airo, 2004, Intravenous cyclophosphamide therapy for systemic sclerosis. A single center experience and a review of the literature with pooled analysis of lung function tests results, Clin Exp Rheumatol, 22, 573
Cossio, 2002, Life-threatening complications of systemic sclerosis, Crit Care Clin, 18, 819, 10.1016/S0749-0704(02)00023-4
Zandman-Goddard, 2005, New therapeutic strategies for systemic sclerosis—a critical analysis of the literature, Clin Dev Immunol, 12, 165, 10.1080/17402520500233437
Ramirez, 2004, Pulmonary arterial hypertension in systemic sclerosis: clinical manifestations, pathophysiology, evaluation, and management, Treat Respir Med, 3, 339, 10.2165/00151829-200403060-00002